Healthcare Publications Radiotherapy Market

Market Research Future has recently share information about global Radiotherapy Market And about the predictions and related market Conditions with the opinion to make better decision for market key players with the SWOT Analysis and path of revenue sources Global Radiotherapy Market - Overview Radiotherapy is used for the treatment of various types of cancer. The therapy uses high power X-rays to destroy cancerous cells. According to the National Cancer Institute, about 50% of cancer patients receive some type of radiation therapy during their treatment. The radiotherapy treatment are less painful than the chemotherapy and surgeries. The damaged cells are broken down by the natural process of body. The cancerous cells get destroyed totally and does not show its presence in future. The time required is much less in contrast to the chemotherapy. The side effects of the radiotherapy is also nominal as compared to the chemotherapy. Around 4 out of every 10 people are treated for cancer undergo radiotherapy. Normally together with other types of treatment including chemotherapy and surgery. The market for the radiotherapy is increasing as the treatment is quick and easy. The treatment is more effective than chemotherapy and surgery. Though treatment has some side effects but the therapy is widely preferred by doctors. The Global Radiotherapy Market will grow very rapidly at a rate of 7% CAGR during the forecasted period 2017-2023. Get Sample Copy @ GE Healthcare (UK), Siemens (Germany), Cardinal Health (U.S.), Nordion (CA), View ray (U.S.), Fuji Holdings (Japan), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Hologic (U.S.), Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications (IBA) (Belgium), Nordion, Inc. (Canada), C. R. Bard, Inc. (U.S.), Isoray Medical, Inc. (U.S.), RaySearch Laboratories (Sweden), Mevion Medical Systems, Inc. (U.S.), Mitsubishi Electric Corporation (Japan), CIVCO Medical Solutions (U.S.), Brainlab AG (Germany), PRECISIS AG (Germany), Technicas Radiofiscas S.L (Spain), Hitachi Ltd. (Japan), Sumitomo Heavy Industries Ltd. (Japan), ProNova Solutions LLC (U.S.), ProTom International (U.S.), and others are some of the prominent players at the forefront of competition in the global radiotherapy market and are profiled in MRFR Analysis. Industry Updates Jan, 2018 Varian Medical Systems signed an agreement to acquire Sirtex Medical Limited. This acquisition expands Varian's addressable market into interventional oncology to emerge as a global leader in radio embolization. October, 2017 Varian has launched its radiotherapy device ProBeam Compact single-room proton therapy system. July, 2017 View Ray has recently announced the launch of MRI-guided radiation therapy solution, MRIdian Linac. Global Radiotherapy Market – Regional: Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa. America holds the larger market in the radiotherapy the market increasing due to the increasing advancement in the technology. The US is the largest market for the radiotherapy due to the technological advancement. The adoption of new technology is more in this region as the research and development is also more and developing day by day. There are many companies who have already captured the market and developed new technologies for the imaging. The number of cancer patients are more in this region. Europe is the second largest market owing to the advanced technologies due to increasing R&D. The European region is having its own set of regulations for the medical regulations. The expenditures are also more by the government bodies for the healthcare and adoption for the new and sophisticated technologies.